-The Times of India MUMBAI: A Mumbai hospital has put up a notice advising its doctors to avoid prescribing drugs manufactured by Ranbaxy Laboratories. This comes a fortnight after Ranbaxy Laboratories agreed to pay a $500-million penalty to US authorities for "selling adulterated drugs" in the American market. It is not known whether the two are linked. Consultants at Jaslok Hospital said an advisory was put up at the receptionist's circular desk...
More »SEARCH RESULT
Total Matching Records found : 2168
Government's manufacturing zones land in trouble -Yogima Seth Sharma & Dilasha Seth
-The Economic Times NEW DELHI: The government's ambitious manufacturing thrust has run into trouble even before it could take off with many states expressing difficulty in acquiring the vast tracts of land needed to set up dedicated zones. Five states have written to the Department of Industrial Policy and Promotion, requesting it to consider revising the minimum land requirement (from existing 5,000 hectare) for developing National Manufacturing Investment Zones (NMIZs). These include Assam,...
More »Order to stop coal mining in S. Garo Hills -Andrew W Lyngdoh
-The Telegraph Shillong: Perhaps for the first time, the South Garo Hills district administration has ordered all coal mining activities in the district to be stopped following deaths in mining areas caused by negligence. South Garo Hills deputy commissioner Chinmay Gotmare issued the order on Monday under Section 133 CrPC, which pertains to removal of nuisance. While issuing the order, Gotmare observed that it has been made to appear to him that coal...
More »USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman
-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...
More »New bulk drug Export norms to comply with EU standards
-The Hindu The Commerce and Industry Ministry, on Thursday, issued new guidelines for pharmaceutical makers to comply with the European Union (EU) Good Manufacturing Practice (GMP) standards. In a statement issued here, the Ministry says such a move will give a boost to pharma Exports from India. "India has demonstrated its keenness to meet international requirements for Exports of pharmaceutical products yet again by taking timely action for complying with the new...
More »
